Nexien BioPharma, Inc. (NXEN) Research

Nexien BioPharma, Inc., a pharmaceutical firm headquartered in Glendale, Colorado, concentrates its efforts on the research, advancement, and market introduction of cannabinoid-derived medications. The company utilizes both pre-clinical and clinical development paths to address a variety of diseases, medical conditions, and disorders. It adopted its current name in September 2018, having previously operated as Intiva BioPharma Inc.

Market snapshot

Symbol
NXEN
Price
$0.00
Day change
0.00%
Market cap
$7.1K
P/E ratio
-0.10x
52-week range
0.0001-0.0129
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • Acusphere, Inc. (ACUS)
  • Aequus Pharmaceuticals Inc. (AQSZF)
  • Golden Developing Solutions, Inc. (DVLP)
  • IR Biosciences Holdings Inc. (IRBS)
  • Invion Limited (IVIXF)
  • MultiCorp International, Inc. (MCIC)
  • Neptune Wellness Solutions Inc. (NEPTF)
  • Regnum Corp. (RGMP)

Recent insider activity

  • Greenberg Richard S — A-Award (1000000 shares) on 2024-05-23
  • Wasoff Evan L — A-Award (2000000 shares) on 2024-05-23
  • Greenberg Richard S — A-Award (250000 shares) on 2023-10-31
  • Wasoff Evan L — A-Award (250000 shares) on 2023-10-31
  • Goldfarb Robert I — A-Award (250000 shares) on 2023-07-25

Open Nexien BioPharma, Inc. (NXEN) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.